These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32061103)

  • 1. The combination of insulin resistance and visceral adipose tissue estimation improves the performance of metabolic syndrome as a predictor of type 2 diabetes.
    Antonio-Villa NE; Bello-Chavolla OY; Vargas-Vázquez A; Mehta R; Aguilar-Salinas CA;
    Diabet Med; 2020 Jul; 37(7):1192-1201. PubMed ID: 32061103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The atypical presentation of the metabolic syndrome components in black African women: the relationship with insulin resistance and the influence of regional adipose tissue distribution.
    Jennings CL; Lambert EV; Collins M; Levitt NS; Goedecke JH
    Metabolism; 2009 Feb; 58(2):149-57. PubMed ID: 19154946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased mast cell abundance in adipose tissue of metabolic syndrome: relevance to the proinflammatory state and increased adipose tissue fibrosis.
    Gurung P; Moussa K; Adams-Huet B; Devaraj S; Jialal I
    Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E504-E509. PubMed ID: 30620639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of indirect markers of insulin resistance in adult patients with Double Diabetes.
    Ferreira-Hermosillo A; Ibarra-Salce R; Rodríguez-Malacara J; Molina-Ayala MA
    BMC Endocr Disord; 2020 Jun; 20(1):87. PubMed ID: 32539854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic Fat Is Associated With Metabolic Syndrome and Visceral Fat but Not Beta-Cell Function or Body Mass Index in Pediatric Obesity.
    Staaf J; Labmayr V; Paulmichl K; Manell H; Cen J; Ciba I; Dahlbom M; Roomp K; Anderwald CH; Meissnitzer M; Schneider R; Forslund A; Widhalm K; Bergquist J; Ahlström H; Bergsten P; Weghuber D; Kullberg J
    Pancreas; 2017 Mar; 46(3):358-365. PubMed ID: 27941426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between ultrasound measures of abdominal fat distribution and indices of glucose metabolism in a population at high risk of type 2 diabetes: the ADDITION-PRO study.
    Philipsen A; Jørgensen ME; Vistisen D; Sandbaek A; Almdal TP; Christiansen JS; Lauritzen T; Witte DR
    PLoS One; 2015; 10(4):e0123062. PubMed ID: 25849815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study.
    Stabe C; Vasques AC; Lima MM; Tambascia MA; Pareja JC; Yamanaka A; Geloneze B
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):874-81. PubMed ID: 22804918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.
    Lorenzo C; Okoloise M; Williams K; Stern MP; Haffner SM;
    Diabetes Care; 2003 Nov; 26(11):3153-9. PubMed ID: 14578254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Aging on Visceral and Subcutaneous Fat Areas and on Homeostasis Model Assessment of Insulin Resistance and Insulin Secretion Capacity in a Comprehensive Health Checkup.
    Hirose H; Takayama M; Iwao Y; Kawabe H
    J Atheroscler Thromb; 2016; 23(2):207-15. PubMed ID: 26412583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to transform a metabolic syndrome score into an insulin sensitivity value?
    Hermans MP; Bouenizabila E; Ahn SA; Rousseau MF
    Diabetes Metab Res Rev; 2016 Jan; 32(1):87-94. PubMed ID: 26111860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome associates with left atrial dysfunction.
    Nyman K; Granér M; Pentikäinen MO; Lundbom J; Hakkarainen A; Sirén R; Nieminen MS; Taskinen MR; Lundbom N; Lauerma K
    Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):727-734. PubMed ID: 29764718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of magnitude of visceral adipose tissue reduction: Impact on insulin resistance, hyperleptinemia and cardiometabolic risk in adolescents with obesity after long-term weight-loss therapy.
    Campos RMDS; Masquio DCL; Corgosinho FC; Caranti DA; Ganen AP; Tock L; Oyama LM; Dâmaso AR
    Diab Vasc Dis Res; 2019 Mar; 16(2):196-206. PubMed ID: 30688518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
    Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
    Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of excluding hyperglycemia from international diabetes federation metabolic syndrome diagnostic criteria on prevalence of the syndrome and its association with microvascular complications, in adult patients with type 1 diabetes.
    Lecumberri E; Nattero-Chávez L; Quiñones Silva J; Alonso Díaz S; Fernández-Durán E; Dorado Avendaño B; Escobar-Morreale HF; Luque-Ramírez M
    Endocrine; 2022 Jun; 76(3):601-611. PubMed ID: 35349030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic basis of atherogenic dyslipidemia.
    Vinik AI
    Clin Cornerstone; 2005; 7(2-3):27-35. PubMed ID: 16473258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome.
    Lord J; Thomas R; Fox B; Acharya U; Wilkin T
    BJOG; 2006 Oct; 113(10):1203-9. PubMed ID: 16753044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Visceral-Fat-Area-to-Hip-Circumference Ratio as a Predictor for Insulin Resistance in a Chinese Population with Type 2 Diabetes.
    Zhang S; Huang YP; Li J; Wang WH; Zhang MY; Wang XC; Lin JN; Li CJ
    Obes Facts; 2022; 15(4):621-628. PubMed ID: 35724630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of diagnostic criteria for metabolic syndrome to identify insulin resistance].
    Butnoriene J; Norkus A; Bunevicius R; Lasas L
    Medicina (Kaunas); 2006; 42(6):455-63. PubMed ID: 16816539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.